Ramón y Cajal Health Research Institute (IRYCIS)

Address Ctra. Colmenar Viejo Km 9,100
28034 – Madrid
Platforms Biomarkers, Vaccines

The Ramón y Cajal Health Research Institute (IRYCIS) is the result of the association of five different entities; i) University Hospital Ramón y Cajal, which is the heart of our institute; ii) the Biomedical Research Foundation of the Hospital, giving support to all the research and innovation activities; iii) Alcalá de Henares University, that gives the ‘university’ character to the Hospital; and iv) two of the most important universities of Spain, Complutense University of Madrid and Autónoma University of Madrid, contributing with some associated research groups from different faculties (Biology, Medicine, Chemistry, Physics, etc)

In our name, in the heart of our acronym and in our logo we exhibit our pride to feel followers of the biomedical research path opened by Dr. Santiago Ramón y Cajal.

Outstanding history of medical research

The core of our Institute, University Hospital Ramón y Cajal, has an outstanding history of medical research, which has been developed over the last forty years in cooperation with various national and international institutions. We believe that we are now prepared not only to be officially recognized for the poles of growth of biomedical research, but also to become an institutional framework capable of making our investigation a significant element in the scientific and economic development of Spain. To do this we have become a Health Research Institute.

On the way to the IRYCIS consolidation, we have noble and faithful companions that provide us support and encouragement: the Madrid Health Service (SERMAS) and the National Health Institute Carlos III of the Ministry of Economy and Competitiveness, to which we wish to express our deepest gratitude.

Five scientific areas

IRYCIS research is organized in five scientific areas: 1. Neuroscience and Sense Organs; 2. Microbiology, Immunology and Infection; 3. Chronic Diseases and Cancer; 4. Epidemiology and Health Technology; 5. Cardiometabology and Systems Pathology.

All these areas are composed by nearly 30 research groups that have achieved well established scientific and organizational standards and which are in leading positions both in the national and international biomedical research fields.

IRYCIS has also 18 facilities offering technical and scientifically services to our researchers: Animal Facilities and Experimental Surgery; Biobank; Biostatistics; Bioinformatics; Clinical Research and Clinical Trials Unit; Non-Ionizing Studies; Translational Genomics (NGS); Confocal microscopy; Proteomics; Sinaptic Plasticity Characterization; miRNAs-based Biomarkers and Therapeutic Targets; Virology and Molecular Epidemiology of HIV; Histology; Lipids and Lipoproteins; Microarrays; Oligoclonal Bands Determination; Molecular Quantification and Characterization; Aptamers Laboratory.

Common space

IRYCIS enables all its members to share a common space to share ideas and projects in order to ensure convergence of scientific progress towards the needs of our society.

Our people:

  • 600+ people devoted to research
  • 5 research areas
  • 28 research groups
  • 18 research facilities
  • 60+ networks, consortiums and platforms

Our active projects:

  • 700+ clinical trials
  • 300+ public and private projects
  • 14 european projects
  • 50 innovation projects
  • 18 patents and know-how in an exploitation stage

Our publications:

  • 600+ publications per year
  • 3000+ accumulated impact factor
  • 25% first decile papers
  • 52% first quartile papers

Our education:

  • 30+ research seminars per year
  • 60+ courses and scientific events organized per year
  • 800+ hours
  • 6000+ attendants


Like what you read? Share your thoughts!